POST MARKETING SURVEILLANCE OF CAPTOPRIL (FOR HYPERTENSION) - A PRELIMINARY-REPORT

被引：54

作者：

CHALMERS, D ^{[1
]}

DOMBEY, SL ^{[1
]}

LAWSON, DH ^{[1
]}

机构：

[1] GLASGOW ROYAL INFIRM,DEPT CLIN PHARMACOL,GLASGOW G4 0SF,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 24卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03179.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：343 / 349

页数：7

共 18 条

[1] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - MORTALITY DURING 2ND, 3RD, AND 4TH YEARS OF FOLLOW UP [J].

COLINJONES, DG ;

LANGMAN, MJS ;

LAWSON, DH ;

VESSEY, MP .

BMJ-BRITISH MEDICAL JOURNAL, 1985, 291 (6502) :1084-1088

[2] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12 MONTH MORTALITY REPORT [J].

COLINJONES, DG ;

LANGMAN, MJS ;

LAWSON, DH ;

VESSEY, MP .

BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6379) :1713-1716

[3] CIMETIDINE AND GASTRIC-CANCER - PRELIMINARY-REPORT FROM POST-MARKETING SURVEILLANCE STUDY [J].

COLINJONES, DG ;

LANGMAN, MJS ;

LAWSON, DH ;

VESSEY, MP .

BRITISH MEDICAL JOURNAL, 1982, 285 (6351) :1311-1313

[4]

COLINJONES DG, 1985, Q J MED, V54, P215

[5]

COULTER DM, 1986, MONITORING DRUG SAFE, P119

[6] THE EFFECTS OF ANTIHYPERTENSIVE THERAPY ON THE QUALITY-OF-LIFE [J].

CROOG, SH ;

LEVINE, S ;

TESTA, MA ;

BROWN, B ;

BULPITT, CJ ;

JENKINS, CD ;

KLERMAN, GL ;

WILLIAMS, GH .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1657-1664

[7] MONITORING ADVERSE REACTIONS TO DRUGS [J].

DOLLERY, CT ;

RAWLINS, MD .

BRITISH MEDICAL JOURNAL, 1977, 1 (6053) :96-97

[8]

EDWARDS CRW, 1985, LANCET, V1, P30

[9]

FERGUSON RK, 1977, LANCET, V1, P775

[10]

GRAHAMESMITH DG, 1986, REPORT WORKING PARTY

← 1 2 →